Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 545-552

  Woelber, Linn ^a   Mahner, Sven ^a   Voelker, Katharina ^a   Eulenburg, Christine Zu ^a   Gieseking, Friederike ^a   Choschzick, Matthias ^a   Jaenicke, Fritz ^a   Schwarz, Joerg ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Lymph node metastasis; Prognosis; SCC Ag; Staging; Survival; Vulvar cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; VULVA CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; VULVAR NEOPLASMS;

EID: 61449245756     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Institute NC: The Surveillance, Epidemiology and End Results (SEER) program, 2008. Available at http://seer.cancer.gov/statfacts/html/vulva.html? statfacts_page=vulva.html&x=9&y=20.
3. Stroup AM, Harlan LC and Trimble EL: Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol 108(3): 577-583, 2008.
4. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G and Leodolter S: Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 45: 613-615, 2000.
5. Messing MJ and Gallup DG: Carcinoma of the vulva in young women. Obstet Gynecol 86: 51-54, 1995.
6. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E and Bouma J: The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 57: 327-334, 1995.
7. Gonzalez Bosquet J, Magrina JF, Gaffey TA, Hernandez JL, Webb MJ, Cliby WA and Podratz KC: Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 97: 828-833, 2005.
8. Iversen T, Aalders JG, Christensen A and Kolstad P: Squamous cell carcinoma of the vulva: A review of 424 patients, 1956-1974. Gynecol Oncol 9: 271-279, 1980.
9. Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, Solda M, Coscio S, Spinetti G, Maneo A, Ferrero A and Konishi De Toffoli G: Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter ctf study. Cancer 89: 116-122, 2000.
10. Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, Vecchione F and Kusamura S: Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol 102: 333-337, 2006.
11. Rhodes CA, Cummins C and Shafi MI: The management of squamous cell vulval cancer: A population based retrospective study of 411 cases. Br J Obstet Gynaecol 105: 200-205, 1998.
12. van der Velden J and Hacker NF: Prognostic factors in squamous cell cancer of the vulva and the implications for treatment. Curr Opin Obstet Gynecol 8: 3-7, 1996.
13. Woolderink JM, de Bock GH, de Hullu JA, Davy MJ, van der Zee AG and Mounts MJ: Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol 103: 293-299, 2006.
14. Andreasson B and Nyboe J: Value of prognostic parameters in squamous cell carcinoma of the vulva. Gynecol Oncol 22: 341-351, 1985.
15. Podratz KC, Symmonds RE, Taylor WF and Williams TJ: Carcinoma of the vulva: Analysis of treatment and survival. Obstet Gynecol 61: 63-74, 1983.
16. Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, Cheung MK, Berman ML and Disaia PJ: Margin distance and other clinicopathologic prognostic factors in vulvar carcinoma: A multivariate analysis. Gynecol Oncol 104: 636-641, 2007.
17. Hefler L, Obermair A, Tempfer C, van Route M, Maenner G, Reinthaller A, Leodolter S and Kainz C: Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer 84: 299-303, 1999.
18. Hopkins MP, Reid GC and Morley GW: The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 75: 1001-1005, 1990.
19. De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, Aalders JG, Mourits MJ and Van Der Zee AG: Vulvar carcinoma. The price of less radical surgery. Cancer 95: 2331-2338, 2002.
20. Piura B, Masotina A, Murdoch J, Lopes A, Morgan P and Monaghan J: Recurrent squamous cell carcinoma of the vulva: A study of 73 cases. Gynecol Oncol 48: 189-195, 1993.
21. Sobin LH and Wittekind CH: TNM Classification of Malignant Tumors, 5th. ed. New York, John Wiley & Sons, Inc., 1997.
22. Fons G, Burger MP, Ten Kate FJ and van der Velden J: Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays. Int J Gynecol Pathol 26: 188-193, 2007.
23. Heatley MK: Prognostic factors associated with vulval carcinoma in women aged above and below 65 years. J Obstet Gynaecol 23: 664-665, 2003.
24. Hefler LA, Sliutz G, Leodolter S, Speiser P, Joura E, Reinthaller A and Kohlberger P: Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer. Gynecol Oncol 97: 904-907, 2005.
25. Kohlberger P, Kainz C, Breitenecker G, Gitsch G, Sliutz G, Kolbl H, Tschachler E and Reinthaller A: Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma. Cancer 76: 1786-1789, 1995.
26. Kurzl R and Messerer D: Prognostic factors in squamous cell carcinoma of the vulva: A multivariate analysis. Gynecol Oncol 32: 143-150, 1989.
27. Levato F, Bianchi A, Campobasso C, Martinello R, Pansini F, Grandi E and Mollica G: Risk factors in vulvar carcinoma recurrences. Eur J Gynaecol Oncol 14: 71-75, 1993.
28. Narayansingh GV, Miller ID, Sharma M, Welch CJ, Sharp L, Parkin DE and Cruickshank ME: The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br J Cancer 92: 222-224, 2005.
29. Rosenthal AN, Hopster D, Ryan A and Jacobs IJ: Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. Br J Cancer 88: 251-256, 2003.
30. Salmaso R, Zen T, Zannol M, Perin D, Marchiori S and Marchetti M: Prognostic value of protein p53 and Ki-67 in invasive vulvar squamous cell carcinoma. Eur J Gynaecol Oncol 21: 479-483, 2000.
31. Iversen T, Abeler V and Kolstad P: Squamous cell carcinoma in situ of the vulva. A clinical and histopathological study. Gynecol Oncol 11: 224-229, 1981.
32. Magrina JF, Webb MJ, Gaffey TA and Symmonds RE: Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol 134: 453-459, 1979.
33. Yamawaki T, Takeshima N, Shimizu Y, Teshima H and Hasumi K: Serum levels of squamous cell carcinoma antigen and carcinoembryonic antigen as tumor markers of vulvar cancer. J Obstet Gynaecol Res 22: 341-346, 1996.
34. van der Sijde R, de Bruijn HW, Krans M, Bouma J and Aalders JG: Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 35: 227-232, 1989.
35. Gadducci A, Tana R, Cosio S and Genazzani AR: The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature. Crit Rev Oncol Hematol 66: 10-20, 2008.